SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001683168-24-003113
Filing Date
2024-05-08
Accepted
2024-05-08 17:02:05
Documents
7
Period of Report
2024-06-17

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT phio_def14a.htm DEF 14A 479237
2 GRAPHIC image_001.jpg GRAPHIC 2140
3 GRAPHIC image_002.jpg GRAPHIC 2129
4 GRAPHIC image_003.jpg GRAPHIC 10260
5 GRAPHIC image_004.jpg GRAPHIC 11696
6 GRAPHIC image_005.jpg GRAPHIC 1044075
7 GRAPHIC image_006.jpg GRAPHIC 395999
  Complete submission text file 0001683168-24-003113.txt   2497273
Mailing Address 11 APEX DRIVE, SUITE 300A PMB 2006 MARLBOROUGH MA 01752
Business Address 11 APEX DRIVE, SUITE 300A PMB 2006 MARLBOROUGH MA 01752 (508) 767-3861
Phio Pharmaceuticals Corp. (Filer) CIK: 0001533040 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36304 | Film No.: 24927300
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)